1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
